Evidence map›Paper›PMID 29756455›Full record

ArticleAIDS research and human retroviruses2018

Characterization of the Transmitted Virus in an Ongoing HIV-1 Epidemic Driven by Injecting Drug Use.

Elena Dukhovlinova, Alexey Masharsky, Aleksandra Vasileva, Alessandro Porrello, Shuntai Zhou, Olga Toussova, Sergei Verevochkin, Ekaterina Akulova, Dmitrij Frishman, David Montefiori and 6 more

Open access · greenAbstract read
In one paragraph

Article in AIDS research and human retroviruses, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 2 countries.

Elena Dukhovlinova1 Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill , Chapel Hill, North Carolina.
Alexey Masharsky2 Peter the Great St. Petersburg Polytechnic University , St. Petersburg, Russian Federation.
Aleksandra Vasileva2 Peter the Great St. Petersburg Polytechnic University , St. Petersburg, Russian Federation.
Alessandro Porrello1 Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill , Chapel Hill, North Carolina.
Shuntai Zhou1 Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill , Chapel Hill, North Carolina.
Olga Toussova3 Pavlov State Medical University , St. Petersburg, Russian Federation.
Sergei Verevochkin2 Peter the Great St. Petersburg Polytechnic University , St. Petersburg, Russian Federation.
Ekaterina Akulova4 The Biomedical Center , St. Petersburg, Russian Federation.
Dmitrij Frishman2 Peter the Great St. Petersburg Polytechnic University , St. Petersburg, Russian Federation.
David Montefiori5 Laboratory for AIDS Vaccine Research and Development, Department of Surgery, Duke University , Durham, North Carolina.
Celia Labranche5 Laboratory for AIDS Vaccine Research and Development, Department of Surgery, Duke University , Durham, North Carolina.
Irving Hoffman6 School of Medicine, University of North Carolina at Chapel Hill , Chapel Hill, North Carolina.
William Miller7 College of Public Health, The Ohio State University , Columbus, Ohio.
Myron S Cohen6 School of Medicine, University of North Carolina at Chapel Hill , Chapel Hill, North Carolina.
Andrei P Kozlov2 Peter the Great St. Petersburg Polytechnic University , St. Petersburg, Russian Federation.
Ronald Swanstrom1 Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill , Chapel Hill, North Carolina.
University of North Carolina at Chapel Hill · USPeter the Great St. Petersburg Polytechnic University · RUFirst Pavlov State Medical University of St. Petersburg · RUThe Ohio State University · US

Funding

Virology, Immunology, and Microbiology CoreP30AI050410 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVID M. MARGOLIS · 2001 to 2026
$76.9M
NIAID NIH HHS P30 AI050410
6 · The paper itself

Abstract

Understanding features of the HIV-1 transmission process has the potential to inform biological interventions for prevention. We have examined the transmitted virus in a cohort of people who inject drugs and who are at risk of HIV-1 infection through blood contamination when injecting in a group. This study focused on seven newly infected participants in St. Petersburg, Russia, who were in acute or early infection. We used end-point dilution polymerase chain reaction to amplify single viral genomes to assess the complexity of the transmitted virus. We also used deep sequencing to further assess the complexity of the virus. We interpret the results as indicating that a single viral variant was transmitted in each case, consistent with a model where the exposure to virus during transmission was limited. We also looked at phenotypic properties of the viral Env protein in isolates from acute and chronic infection. Although differences were noted, there was no consistent pattern that distinguished the transmitted variants. Similarly, despite the reduced genetic heterogeneity of the more recent subtype A HIV-1 epidemic in St. Petersburg, we did not see reduced variance in the neutralization properties compared to isolates from the more mature subtype C HIV-1 epidemic. Finally, in looking at members of injecting groups related to the acute HIV-1 infection/early subjects, we found examples of sequence linkage consistent with ongoing and rapid spread of HIV-1 in these groups. These studies emphasize the dynamic nature of this epidemic and reinforce the idea that improved prevention methods are needed.

Indexed as

Drug UsersEpidemicsCohort Studiesenv Gene Products, Human Immunodeficiency VirusGenetic VariationGenome, ViralHIV-1HIV InfectionsHumansMolecular EpidemiologyNeutralization TestsPhylogenyPolymerase Chain ReactionRussiaSequence Analysis, DNASubstance Abuse, Intravenousenv Gene Products, Human Immunodeficiency Virusacute HIV infectiongenetic bottleneckHIV envelopeHIV in RussiaHIV transmissionpeople who use drugs

Identifiers

PMID29756455
PMCPMC6204568
OpenAlexW2804989214

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.